IGFBP5 Regulates Adhesion-Driven Bortezomib Resistance in Multiple Myeloma
Researchers identified IGFBP5 as a negative regulator of adhesion-mediated bortezomib resistance in multiple myeloma that modulates FAK/Src signaling.
Researchers identified IGFBP5 as a negative regulator of adhesion-mediated bortezomib resistance in multiple myeloma that modulates FAK/Src signaling.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.